期刊
JOURNAL OF HEMATOLOGY & ONCOLOGY
卷 10, 期 -, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/s13045-017-0410-6
关键词
RNA modification; m(6)A; Leukemia; Acute myeloid leukemia; TP53 mutation
资金
- National Health and Medical Research Council of Australia [1061906, 1080530, 1128175, 1126306]
- Cancer Council of NSW
- Cure the Future
- an anonymous foundation
- Cancer Institute of NSW
- National Health and Medical Research Council of Australia [1126306] Funding Source: NHMRC
Methylation of N-6 adenosine (m(6)A) is known to be important for diverse biological processes including gene expression control, translation of protein, and messenger RNA (mRNA) splicing. However, its role in the development of human cancers is poorly understood. By analyzing datasets from the Cancer Genome Atlas Research Network (TCGA) acute myeloid leukemia (AML) study, we discover that mutations and/or copy number variations of m(6)A regulatory genes are strongly associated with the presence of TP53 mutations in AML patients. Further, our analyses reveal that alterations in m(6)A regulatory genes confer a worse survival in AML. Our work indicates that genetic alterations of m(6)A regulatory genes may cooperate with TP53 and/or its regulator/downstream targets in the pathogenesis and/or maintenance of AML.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据